We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

NXT:LSENext plc Analysis

Data as of 2026-03-10 - not real-time

£12,780.00

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Next plc is trading below its twentieth‑day moving average while sitting just above its two‑hundred‑day average, indicating a modest downtrend that is not yet severe. The fourteen‑day RSI sits in the low‑forties, suggesting the stock is not overbought nor oversold, and the MACD histogram remains negative, reinforcing a bearish short‑term momentum. Volume has been increasing, providing decent liquidity, and the beta is low, giving the stock a defensive characteristic within the consumer‑cyclical sector. However, the thirty‑day volatility is in the mid‑twenties percent, reflecting a relatively choppy price environment. The discounted cash‑flow model implies a fair value notably below the current price, pointing to an overvalued market level with upside potential of roughly fifteen percent if the price reverts toward intrinsic value. Fundamentals remain strong: revenue growth is near ten percent, margins are solid, ROE is exceptionally high, and free cash flow comfortably covers the dividend, which yields just under two percent with a payout ratio around thirty‑five percent. Recent Citi commentary highlights exposure to Middle‑East volatility and dollar strength as macro risks for UK fashion retailers, adding a geographic and currency overlay to the risk profile.
Given the blend of strong earnings, sustainable dividend, and defensive beta, the medium‑term outlook is favorable, but short‑term price pressure from bearish technical signals and overvaluation suggests caution. Investors with a longer horizon may consider holding for dividend income while monitoring valuation compression, whereas traders focused on near‑term moves might look for downside protection.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • bearish MACD momentum
  • price below twentieth‑day moving average
  • increasing volume providing liquidity

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • strong return on equity and profit margins
  • sustainable dividend with low payout ratio
  • potential upside toward discounted cash‑flow fair value

Long Term

> 3 years
Neutral
Model confidence: 7/10

Key Factors

  • consistent earnings growth and cash‑flow generation
  • defensive low‑beta profile in a cyclical sector
  • exposure to geographic headwinds balanced by diversified markets

Key Metrics & Analysis

Financial Health

Revenue Growth9.90%
Profit Margin12.38%
P/E Ratio19.4
ROE48.51%
ROA14.37%
Debt/Equity109.30
P/B Ratio880.7
Op. Cash Flow£1.2B
Free Cash Flow£667.8M

Technical Analysis

TrendNeutral
RSI40.8
Support£12,630.00
Resistance£13,521.35
MA 20£13,039.25
MA 50£13,370.30
MA 200£12,936.55
MACDBearish
VolumeIncreasing
Fear & Greed Index76.91

Valuation

Fair Value£10,868.20
Target Price£14,744.08
Upside/Downside15.37%
GradeOvervalued
TypeGrowth
Dividend Yield1.92%

Risk Assessment

Beta0.25
Volatility24.61%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.